Exploring the role of short-course cyclosporin a therapy in preventing homograft valve calcification after transplantation

Cellular Immunology

Volumn 287, Issue 1, 2014, Pages 36-45

  Chang, Qing ^a   Jing, Hui ^a   Sun, Mingshu ^a   Xu, Ping ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Calcification; Cyclosporine A; Degeneration; Homograft valve; Immunology; Rat; Transplantation

Indexed keywords

CALCIUM; CD40 LIGAND; CD71 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ALPHA;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE REPLACEMENT; ARTICLE; CALCIFICATION; CONTROLLED STUDY; FEMALE; HOMOGRAFT VALVE CALCIFICATION; IMMUNE RESPONSE; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT COURSE THERAPY; SPRAGUE DAWLEY RAT; WISTAR RAT;

CALCIFICATION; CYCLOSPORINE A; DEGENERATION; HOMOGRAFT VALVE; IMMUNOLOGY; RAT; TRANSPLANTATION;

ALLOGRAFTS; ANIMALS; ANTIGENS, CD; AORTIC VALVE; CALCIUM; CYCLOSPORINE; FEMALE; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; TRANSPLANTATION IMMUNOLOGY; VASCULAR CALCIFICATION;

EID: 84891120515     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.11.008     Document Type: Article

References (33)

1. Ali A., Abu-Omar Y., Patel A., et al. Propensity analysis of survival after subcoronary or root replacement techniques for homograft aortic valve replacement. J. Thorac. Cardiovasc. Surg. 2009, 137(2):334-341.
2. Musci M., Yuguo W., Hiibler M., et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience. J. Thorac. Cardiovasc. Surg. 2010, 139(3):665-673.
3. Kilian E., Fries F., Kowert A., et al. Homograft implantation for aortic valve replacement since 15 years: results and follow-up. Heart. Surg. Forum 2010, 13(4):238-242.
4. Vohra H.A., Whistance R.N., Chia A.X., et al. Long-term follow-up after primary complete repair of common arterial trunk with homograft: a 40-year experience. J. Thorac. Cardiovasc. Surg. 2010, 140(2):325-329.
5. Herisson F., Heymann M.F., Chétiveaux M., et al. Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis 2011, 216(2):348-354.
6. Osinalde N., Moss H., Arrizabalaga O., et al. Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. J. Proteomics 2011, 75(1):177-191.
7. Hendrikx T.K., Klepper M., Ijzermans J., et al. Clinical rejection and persistent immune regulation in kidney transplant patients. Transpl. Immunol. 2009, 21(3):129-135.
8. Marmor M.D., Julius M. Role for lipid rafts in regulating interleukin-2 receptor signaling. Blood 2001, 98(5):1489-1497.
9. Nakase I., Gallis B., Takatani-Nakase T., et al. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett. 2009, 274(2):290-298.
10. Kono M., Kondo T., Takagi Y., et al. Morphological definition of CD71 positive reticulocytes by various staining techniques and electron microscopy compared to reticulocytes detected by an automated hematology analyzer. Clin. Chim. Acta 2009, 404(2):105-110.
11. Daniels T.R., Bernabeu E., Rodríguez J.A., et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim. Biophys. Acta-Gen. Subjects 2012, 1820(3):291-317.
12. Baker R.L., Wagner D.H., Haskins K. CD40L on NOD CD4 T cells contributes to their activation and pathogenicity. J. Autoimmun. 2008, 31(4):385-392.
13. Mavroudi I., Papadaki H.A. The Role of CD40L/CD40L ligand interactions in bone marrow granulopoiesis. Scientific World Journal 2011, 11:45-89.
14. Urban D., Thanabalasingam U., Stibenz D., et al. CD40L/CD40LL interaction induces E-selectin dependent leukocyte adhesion to human endothelial cells and inhibits endothelial cell migration. Biochem. Biophys. Res. Commun. 2011, 404(1):448-452.
15. Poggi M., Jager J., Paulmyer-Lacroix O., et al. The inflammatory receptor CD40L is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 2009, 52(6):1152-1163.
16. den Hamer I., Hepkema B., Prop J., et al. Hla antibodies specific for cryopreserved heart valve "homografts" in children. J. Thorac. Cardiovasc. Surg. 1997, 113(2):417-419.
17. Hoekstra F., Knoop C., Vaessen L., et al. Donor-specific cellular immune response against human cardiac valve allografts. J. Thorac. Cardiovasc. Surg. 1996, 112(2):281-286.
18. Muratov R., Britikov D., Sachkov A., et al. New approach to reduce allograft tissue immunogenicity. Experimental data. Interact. Cardiovasc. Thorac. Surg. 2010, 10(3):408-412.
19. Kneib C., von Glehn C.Q.C., Costa F.D.A., et al. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts. Tissue Antigens 2012, 80(2):165-174.
20. Lehr E.J., Rayat G.R., Chiu B., et al. Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches. J. Thorac. Cardiovasc. Surg. 2011, 141(4):1056-1062.
21. Brockbank K.G.M., Song Y.C. Mechanisms of bioprosthetic heart valve calcification1. Transplantation 2003, 75(8):1133-1135.
22. Chang Q., Xu P., et al. Analysis of the factors which influence allograft calcification after aorta transplantation of allogenetic rat. Xi bao yu fen zi mian yi xue za zhi 2006, 22(1):106.
23. Gong X.J., Li S.X., Pang X.Y., et al. Correlative study of calcium content in rat aortic valved homograft tissue. Chin. J. Exp. Surg. 2009, 26(3):339-341.
24. Chen W.S., Liu W.Y., Wang G., et al. The correlation between immune response and calcium content in implanted valved aortic homograft conduit of neonate rabbit. Chin. Heart. J. 2002, 14(1):22-25.
25. Pupka A., Skóra J., Janczak D., et al. Immunosuppression in the treatment of vascular prosthesis infection with arterial transplantation. Pol. Merkuriusz. Lek. 2004, 16(91):8.
26. Teebken O.E., Bisdas T. Immunosuppression following fresh arterial homograft implantation for aortic graft infections. Eur. J. Vasc. Endovasc. Surg. 2011, 41(6):859. (author reply 859).
27. Charles Yankah A., Wottge H.U., Müller-Ruchholtz W. Short-course cyclosporin A therapy for definite allograft valve survival immunosuppression in allograft valve operations. Ann. Thorac. Surg. 1995, 60:S146-S150.
28. Li D.Y., Zhang R.F., Zhu H.Y. Study of immunological rejection in implantation of aortic and pulmonary valved homograft. Chin. J. Thorac. Cardiovasc. Surg. 2000, 1:018.
29. Taflin C., Charron D., Glotz D., et al. Immunological function of the endothelial cell within the setting of organ transplantation. Immunol. Lett. 2011, 139(1):1-6.
30. Miller D.V., Edwards W.D., Zehr K.J. Endothelial and smooth muscle cell populations in a decellularized cryopreserved aortic homograft (SynerGraft) 2years after implantation. J. Thorac. Cardiovasc. Surg. 2006, 132(1):175-176. (el).
31. Post I.C.J.H., Weenink R.P., Wijk A.C.W.A., et al. Characterization and quantification of porcine circulating endothelial cells. Xenotransplantation 2013, 20(1):18-26.
32. Wallbrecht K., Drick N., Hund A.C., et al. Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. Exp. Dermatol. 2011, 20(12):980-985.
33. Ferrero M.C., Bregante J., Delpino M., et al. Proinflammatory response of human endothelial cells to Brucella infection. Microbes Infect. 2011, 13(10):852-861.